Control	NN
of	IN
virus	NN
reactivation	NN
arrests	NNS
pulmonary	JJ
herpesvirus-induced	JJ
fibrosis	NN
in	IN
IFN-gamma	NN
receptor-deficient	JJ
mice	NNS
.	.

RATIONALE	NN
:	:
Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
chronic	JJ
progressive	JJ
fibrotic	JJ
lung	NN
disorder	NN
of	IN
unknown	JJ
cause	NN
.	.

Several	JJ
studies	NNS
suggest	VBP
an	DT
association	NN
between	IN
Epstein-Barr	JJ
virus	NN
pulmonary	JJ
infection	NN
and	CC
the	DT
development	NN
of	IN
IPF	NN
.	.

OBJECTIVES	NNS
:	:
To	TO
determine	VB
whether	IN
reduction	NN
of	IN
gamma-herpesvirus	NN
reactivation	NN
from	IN
latency	NN
would	MD
alter	VB
progressive	JJ
lung	NN
fibrogenesis	NN
in	IN
an	DT
animal	NN
model	NN
of	IN
virus-induced	JJ
pulmonary	JJ
fibrosis	NN
.	.

METHODS	NNS
:	:
IFN-gamma	NN
receptor-deficient	JJ
(	(
IFN-gammaR	NN
(	(
-	:
/	:
-	:
)	)
)	)
mice	NNS
infected	JJ
intranasally	RB
with	IN
murine	JJ
gamma-herpesvirus	NN
68	CD
(	(
MHV68	NN
)	)
develop	VBP
lung	NN
fibrosis	NN
that	WDT
progresses	VBZ
for	IN
up	RB
to	TO
at	IN
least	JJS
180	CD
days	NNS
after	IN
initial	JJ
infection	NN
.	.

Viral	JJ
replication	NN
during	IN
the	DT
chronic	JJ
phase	NN
of	IN
infection	NN
was	VBD
controlled	VBN
by	IN
two	CD
methods	NNS
:	:
the	DT
administration	NN
of	IN
cidofovir	NN
,	,
an	DT
antiviral	JJ
drug	NN
effective	JJ
at	IN
clearing	VBG
lytic	JJ
but	CC
not	RB
latent	JJ
virus	NN
,	,
and	CC
by	IN
using	VBG
a	DT
mutant	JJ
gamma-herpesvirus	NN
defective	JJ
in	IN
virus	NN
reactivation	NN
from	IN
latency	NN
.	.

MEASUREMENTS	NNS
AND	CC
MAIN	NNS
RESULTS	NNS
:	:
Ten	CD
percent	NN
of	IN
the	DT
asymptomatic	JJ
MHV68-infected	JJ
animals	NNS
that	WDT
received	VBD
antiviral	JJ
treatment	NN
beginning	NN
on	IN
Day	NN
45	CD
postinfection	NN
had	VBD
severe	JJ
pulmonary	JJ
fibrosis	NN
compared	VBN
with	IN
40	CD
%	NN
of	IN
the	DT
control	NN
saline-treated	JJ
animals	NNS
.	.

Absence	NN
of	IN
severe	JJ
fibrosis	NN
was	VBD
also	RB
observed	VBN
in	IN
IFN-gammaR	NN
(	(
-	:
/	:
-	:
)	)
mice	NNS
infected	VBN
with	IN
the	DT
defective	JJ
reactivation	NN
mutant	JJ
MHV68	NN
v-cyclin	NN
stop	NN
.	.

Decreased	VBN
fibrosis	NN
was	VBD
associated	VBN
with	IN
lower	JJR
levels	NNS
of	IN
transforming-growth-factor-beta	NN
,	,
vascular-endothelial-growth-factor	NN
,	,
and	CC
markers	NNS
of	IN
macrophage	NN
alternative	NN
activation	NN
.	.

When	WRB
antiviral	JJ
treatment	NN
was	VBD
administered	VBN
on	IN
Day	NN
60	CD
in	IN
symptomatic	JJ
animals	NNS
,	,
survival	NN
improved	VBN
from	IN
20	CD
to	TO
80	CD
%	NN
compared	VBN
with	IN
untreated	JJ
symptomatic	JJ
animals	NNS
,	,
but	CC
lung	NN
fibrosis	NN
persisted	VBD
in	IN
60	CD
%	NN
of	IN
the	DT
mice	NNS
.	.

CONCLUSIONS	NNS
:	:
MHV68-induced	JJ
fibrosis	NN
is	VBZ
a	DT
result	NN
of	IN
viral	JJ
lytic	JJ
replication	NN
during	IN
chronic	JJ
lung	NN
herpesvirus	NN
infection	NN
in	IN
mice	NNS
.	.

We	PRP
speculate	VBP
that	IN
antiviral	JJ
therapy	NN
might	MD
help	VB
to	TO
control	VB
lung	NN
fibrosis	NN
in	IN
humans	NNS
with	IN
IPF	NN
and	CC
associated	VBN
herpesvirus	NN
infection	NN
.	.

